Project Grant K23NS146645
- Federal Grant Award Summary The University of Michigan received a $633,146 Project Grant award from the National Institute of Neurological Disorders and Stroke (NINDS) under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) program, effective August 4, 2025, with completion targeted for July 31, 2030. The award funds research to identify modifiable factors that reduce vascular cognitive impairment and dementia (VCID) risk in stroke survivors. The...
- Federal Project Grant Award Summary The National Institute of Neurological Disorders and Stroke (NINDS) awarded a $429,000 Project Grant to the Regents of the University of Michigan on August 1, 2025, under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) program. This two-year award, with an ultimate completion date of July 31, 2027, funds research to identify the mechanism of Notch pathway inhibition resistance in glioblastoma (GBM) stem cells. The...
- Federal Grant Award Summary The University of Pennsylvania received a $644,345 Project Grant award from the National Institute of Neurological Disorders and Stroke (NINDS) under the Extramural Research Programs in the Neurosciences and Neurological Disorders program (CFDA 93.853), effective February 11, 2026, with a completion date of December 31, 2030. The project deliverable is a multicenter randomized controlled trial evaluating MyStroke, a web-based, personalized video-based stroke...
- Federal Grant Award Summary The National Institute of Neurological Disorders and Stroke (NINDS) awarded the University of Wisconsin–Madison a Project Grant totaling $494,240 under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) program, effective February 16, 2026, through January 31, 2031. This award funds a five-year research investigation into microRNA (miRNA) degradation mechanisms in post-stroke brain tissue, specifically examining...
- Federal Grant Award Summary The National Institute of Neurological Disorders and Stroke (NINDS) awarded The Trustees of the University of Pennsylvania a $664,458 Project Grant effective September 1, 2025, through August 31, 2030, under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) program. This research initiative focuses on developing and validating a non-invasive optical imaging technology for prehospital detection of large vessel occlusion...
- Federal Grant Award Summary The National Institute of Neurological Disorders and Stroke (NINDS) awarded the Regents of the University of Michigan $587,521 through the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) program on June 1, 2025, with a completion date of April 30, 2030. This project grant supports research into mitochondrial modulation therapy as a therapeutic intervention for traumatic brain injury (TBI), which affects approximately 1.7...
- Federal Grant Award Summary The National Institute of Neurological Disorders and Stroke (NINDS) awarded the University of Alabama at Birmingham $540,236.00 under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) program. This Project Grant, effective September 1, 2025, through August 31, 2030, funds research targeting glial HUR (Human Antigen R), an RNA regulator that drives neuroinflammatory responses in acute ischemic stroke. The research aims to...
- Federal Project Grant Award Summary The National Institute of Neurological Disorders and Stroke (NINDS) awarded Henry Ford Health + Michigan State University Health Sciences a project grant of $431,750 under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) for research investigating a novel therapeutic strategy to treat multi-infarct dementia (MID). The award, effective May 20, 2025, through April 30, 2027, funds preclinical research utilizing...
- Federal Grant Award Summary The National Institute of Neurological Disorders and Stroke (NINDS) awarded the University of Maryland, Baltimore $602,065 under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) program on March 5, 2026, with a completion date of December 31, 2029. This project grant supports fundamental neuroscience research investigating the molecular mechanisms by which SGLT2 (sodium-glucose cotransporter 2) regulates aquaporin-4 (AQP4)...
- Federal Grant Award Summary The National Institute of Neurological Disorders and Stroke (NINDS) awarded the Regents of the University of Michigan a Project Grant of $659,325 under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) program, effective August 1, 2025, through June 30, 2029. This research initiative investigates neuro-immune mechanisms in mutant IDH1 (isocitrate dehydrogenase 1) gliomas to advance understanding of how IDH1 mutations...
The National Institute of Neurological Disorders and Stroke awarded the University of Michigan a $233,280 Project Grant (CFDA 93.853, Extramural Research Programs in the Neurosciences and Neurological Disorders) effective March 1, 2026 through February 28, 2031. The award supports research to identify modifiable systems factors and telestroke-specific determinants associated with delays in acute ischemic stroke (AIS) treatment delivery. Specifically, the research will analyze door-to-needle (DTN) times for intravenous thrombolysis and door-in-door-out (DIDO) times for interhospital transfer in patients receiving telestroke evaluation using national stroke registries and mixed-methods approaches. The project will deliver a first-generation acute telestroke toolkit developed through systems engineering methods and participatory design to optimize treatment timelines and reduce permanent neurological impairment. Research activities include identifying modifiable systems factors using the Get With The Guidelines-Stroke Registry, conducting sequential mixed-methods analysis through the Paul Coverdell Michigan Acute Stroke Registry, and ranking delay-associated factors to inform evidence-based interventions. The deliverables are intended to advance clinical practice by addressing the prolonged DTN and DIDO times observed in telestroke evaluations compared to conventional in-person stroke care.Federal Grant Award Summary
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $233.3k | 2/27/26 |